Joshua Rychak, based in California, United States, is currently a Vice President R and D, Gene Therapy at Poseida Therapeutics, Inc., bringing experience from previous roles at Poseida Therapeutics, Inc.. Joshua Rychak holds a 2000 - 2005 PhD in Biomedical Engineering @ University of Virginia. With a robust skill set that includes Lifesciences, Microscopy, Ultrasound, Inflammation, Medical Imaging and more, Joshua Rychak contributes valuable insights to the industry. Joshua Rychak has 4 emails and 1 mobile phone number on RocketReach.